The non-benign aspects of migraine

References

• Bradshaw P., Parson M. Hemiplegic migraine. A clinical study. Quart. J. Med. 1965; 34: 65–85
   PubMedGoogle Scholar
• Callaghan N. The migraine syndrome in pregnancy. Neurology 1968; 18: 197–199
   PubMed Web of Science ®Google Scholar
• Carey H. M. Principles of oral contraception, 2. Effects of oral contraception. Med. J. Australia 1971; 2: 1242–1250
   Google Scholar
• Carvalho A., et al. Coagulation abnormalities in women taking oral contraceptives. J. Amer. med. Ass. 1977; 237: 875
   Google Scholar
• Collaborative Group for the Study of Stroke in Young Women: Oral contraception and increased risk of cerebral ischemia or thrombosis. New. Engl. J. Med. 1973; 288: 871–878
   PubMed Web of Science ®Google Scholar
• Collaborative Group for the Study of Stroke in Young Women: Oral contraceptives and stroke in young women; associated risk factors. J. Amer. med. Ass. 1975; 231: 718–722
   PubMed Web of Science ®Google Scholar
• Couch J. R., Hassanein R. S. Platelet aggregability in migraine. Neurology 1977; 27: 843–848
   PubMed Web of Science ®Google Scholar
• Cowan C. L., Knox D. L. Migraine optic neuropathy. Ann. Ophthal. 1982; 14: 164–166
   Google Scholar
• Critchley M., Ferguson F. R. Migraine. Lancet 1933; 224: 123–126
   Google Scholar
• D'Andrea G., et al. Letter to the Editor. Platelet behavior in classic migraine: responsiveness to small doses of aspirin. Thromb. Hemostasis 1983; 49: 153
   Google Scholar
• Deshmukh S. V., Meyer J. S. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine. Headache 1977; 17: 101–108
   Google Scholar
• Diamond S., Schenbaum H. Flunarizine, a calcium channel blocker in prophylactic treatment of migraine. Headache 1983; 23: 39–42
   PubMed Web of Science ®Google Scholar
• Flamm E. S., Kim J., Lin J., Ransohoff J. Phosphodiesterase inhibitors and cerebral vasospasm. Arch. Neurol. 1975; 32: 569–571
   Google Scholar
• Flamm E. S., Viau A. J., Ransohoff J., Naftchi N. E. Experimental alterations in cyclic adenosine monophosphate concentrations in cat basilar artery. Neurology 1976; 26: 664–666
   Google Scholar
• Friedman A. P., Merritt H. H. Headache: Diagnosis and Treatment. F. A. Davis Co. 1959
   Google Scholar
• Friedman A. P. Current concepts in the diagnosis and treatment of chronic recurrent headache. Med. Clin. North Amer. 1972a; 56: 1257–1271
   Google Scholar
• Friedman A. P. Migraine headaches. J. Amer. med. Ass. 1972b; 222: 1399–1402
   PubMed Web of Science ®Google Scholar
• Galezowski X. Ophthalmic megrim. The Lancet 1882; 1: 176
   Google Scholar
• Gelmers H. J. Nimodipine, a new calcium antagonist in the prophylactic treatment of migraine. Headache 1983; 23: 106
   PubMed Web of Science ®Google Scholar
• Gilbert C. J. An occurrence of complicated migraine during propranolol therapy. Headache 1982; 22: 81–83
   Google Scholar
• Graveson G. S. Retinal arterial occlusion in migraine. Brit. med. J. 1949; 2: 838–840
   PubMedGoogle Scholar
• Hilton B. P., Cumings J. N. 5-Hydroxytryptamine levels and platelet aggregation response in subjects with acute migraine headache. J. Neurol. Neurosurg. Psychiat. 1972; 35: 505–509
   PubMed Web of Science ®Google Scholar
• Kalendovsky Z., Austin J., Steele P. Increased platelet aggregability in young patients with stroke. Arch. Neurol. 1975; 32: 13–20
   PubMedGoogle Scholar
• Kudrau L. The relationship of headache frequency to hormone use in migraine. Headache 1975; 15: 36–40
   Google Scholar
• Kupersmith M. J., Hass W. K., Chase N. E. Isoproterenol treatment of visual symptoms in migraine. Stroke 1979; 10: 299–305
   PubMed Web of Science ®Google Scholar
• Lance J. W., Anthony M. Some clinical aspects of migraine. A prospective survey of 500 patients. Arch. Neurol. 1966; 15: 356–361
   PubMedGoogle Scholar
• Marcussen R. M., Wolff H. G. Studies on headache. Arch. Neurol. Psychiat. 1950; 63: 42–51
   Google Scholar
• Masi A. T., Dugdale M. Cerebrovascular disease associated with the use of oral contraceptive: a review of the English language literature. Ann. Int. Med. 1970; 72: 111–121
   PubMed Web of Science ®Google Scholar
• Mettler L., Meseck-Selchow B. Oral contraceptives and platelet function. Thromb. Diathesis haemorrh. 1972; 28: 213–220
   Google Scholar
• Nelson E., Gertz S. D., Rennels M., . Ultrastructural changes in the arterial endothelium; possible relationship to atherosclerosis. Cerebral Vascular Diseases, P. Scheinberg, et al. Raven Press, New York 1976; 97–107
   Google Scholar
• O'Neill J. T., Tryastman R. J. Adrenergic receptors in the intra and extracranial vasculature. Neurogenic Control of the Brain Circulation, C. Owman, L. Edvinson. Pergamon Press, New York 1977; 245–265
   Google Scholar
• O'Neill B. P., Mann J. D. Aspirin prophylaxis in migraine. Lancet 1978; 1179–1181
   Google Scholar
• Pearce J. M. S., Foster J. B. An investigation of complicated migraine. Neurology 1965; 15: 333–340
   Google Scholar
• Phillips B. M. Oral contraceptive drugs and migraine. Brit. med. J. 1968; 2: 99
   PubMedGoogle Scholar
• Prendes J. L. Considerations on the use of propranolol in complicated migraine. Headache 1980; 20: 93–95
   Google Scholar
• Raskin N. H., Appenzeller O. Headache Vol. XIX, Major Problems in Internal Medicine. W. B. Saunders & Co., Philadelphia 1980
   Google Scholar
• Ross R. T. Hemiplegic migraine. Canad. med. Assoc. J. 1958; 78: 10–16
   Google Scholar
• Ryan R. E. A controlled study of the effects of oral contraceptives on migraine. Headache 1978; 17: 250–252
   PubMedGoogle Scholar
• Salmon M. L., Winkelman J. Z., Gay A. J. Neuro-ophthalmic sequelae in users of oral contraceptives. J. Amer. med. Ass. 1968; 206: 85–91
   Google Scholar
• Schumacher G., Wolff H. G. Experimental Studies On Headache. Arch. Neurol. Psychiat. 1941; 45: 199–214
   Google Scholar
• Shafey S., Scheinberg P. Neurological Syndromes Occurring in Patients Receiving Synthetic Steroids (Oral Contraceptives). Neurology 1966; 16: 205–211
   Google Scholar
• Somerville B. W. A Study of Migraine in Pregnancy. Neurology 1972; 22: 824–828
   Google Scholar
• Speccavento L. J., Solomon G. D., Mani S. An Association Between Strokes and Migraine in Young Adults (Abstract). Headache 1981; 21: 121
   Google Scholar
• The Canadian Cooperative Study Group A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke. New Engl. J. Med. 1978; 299: 53–59
   PubMed Web of Science ®Google Scholar
• Waters W. E., O'connor P. J. Prevalence of Migraine. J. Neurol. Neurosurg. Psychiat. 1975; 38: 613–616
   PubMed Web of Science ®Google Scholar
• Weinstein J. M., Feman S. S. Ischemic Optic Neuropathy in Migraine. Arch. Ophthal. 1982; 100: 1097
   PubMedGoogle Scholar
• Weiss H. J., Aledort L. M., Kochwa S. The Effect of Salicylates On Hemostatic Properties of Platelets in Man. J. Din. Invest. 1968; 47: 2169–2180
   PubMed Web of Science ®Google Scholar
• Weiss H. J. Anti-Platelet Therapy. New. Engl. J. Med. 1978; 298: 1344–1347
   PubMedGoogle Scholar
• Wessler S., et al. Estrogen-Containing Oral Contraceptive Agents: A Basis For Their Thrombogenicity. J. Amer. Med. Ass. 1976; 236: 2179–2182
   Google Scholar
• Whitty C. W. M., Hockaday J. M., Whitty M. M. The Effect of Oral Contraceptives On Migraine. Lancet 1966; 1: 856–859
   PubMed Web of Science ®Google Scholar